Tequity Advises Bluewave Technology Group on Acquisition by Aspire Systems
Bluewave Marks Tequity's 26th Salesforce Transaction
This strategic acquisition significantly enhances Aspire's Salesforce practice while expanding its delivery capabilities across
About Aspire Systems
Aspire Systems is a global technology services company with a proven track record of enabling businesses worldwide with future-ready software solutions. The company helps clients achieve business agility through its expertise in cloud computing, product engineering, digital transformation, and enterprise solutions. For more information, go to https://www.aspiresys.com.
About Bluewave Technology Group
Bluewave Technology Group is an award-winning Salesforce Summit Consulting Partner, specializing in consulting, development, training, implementation, and integration services across
About Tequity
Tequity Advisors advises enterprise B2B SaaS, Cloud, and IT companies on strategic M&A to drive growth, achieve liquidity, and expertly navigate exit strategies. With decades of experience as executives, consultants, and business owners in the software and technology sectors, Tequity offers unparalleled industry insights and a vast network of strategic, growth-driven buyers. Tequity is committed to facilitating successful M&A transactions that maximize value and fuel long-term success. Discover more at www.tequityadvisors.com.
Media Contact:
M&A Associate
Tequity Advisors
647-870-7006
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/tequity-advises-bluewave-technology-group-on-acquisition-by-aspire-systems-302385668.html
SOURCE Tequity Advisors
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Egypt Launches New Digital Visa-On-Arrival System for a Faster, Seamless Arrival Experience
- Halfpricesoft.com Boosts Compatibility for QuickBooks Nonprofit Users with EzCheckPrinting and Virtual Printer Combo
- Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share